Want to answer the question of investor contribution?

Impact funds face a question that is getting harder to avoid. Limited Partners and regulators no longer only want to see a portfolio full of impactful companies. They increasingly ask what role the fund itself played in making that impact happen: did the capital, the expertise, the network actually contribute to the outcome?

A note on terms before we go further. We deliberately speak of contribution, not attribution. As we explored in our earlier piece on the difference, attribution implies precise causal credit, a standard that even academic researchers rarely meet. Contribution asks a more answerable question: Can a fund show plausible, structured evidence of its role? For the vast majority of funds, contribution is the right ambition, and the good news is that it is reachable with tools that exist today.

Start where you are: A pragmatic priority order

Honesty first: in practice, the most pressing challenge is not methodology. It is the quality and completeness of basic impact data. Many funds still struggle to collect consistent, verified output metrics from their portfolio companies. Debating how much credit to claim for an outcome that has not yet been reliably measured gets the order wrong.

So rather than holding every fund to an academic standard, we suggest a staged approach:

A Pragmatic Priority Order:

• ‍Stage 1, Foundation:
  Consistent, verified impact data collection at portfolio company level. This does not answer the contribution question yet, but lays the foundation for it.‍
• Stage 2, Contribution evidence:
  Qualitative investor contribution assessment via investee surveys. Low cost, high signal, implementable now. This is the focus of this article.‍
• Stage 3, Advanced:
  Capital-share contribution modelling across co-investors, where data quality and co-investor agreement make it feasible.

Most funds we work with are somewhere between Stage 1 and Stage 2. That is fine. Stage 2 is where the credibility gain per unit of effort is highest, and it is the stage this article equips you for.

Two concepts worth separating

The conceptual foundation comes from recent research (Kölbel et al. 2020; Busch et al. 2021): company impact is the change a company's operations achieve in social and environmental parameters. Investor impact, or contribution, is the change the investor's activities achieve in the company's impact.

This distinction separates two strategies. Impact-aligned investments hold companies that have positive impact, without the investor causing it; buying shares of an already well-funded renewable energy company on the secondary market is the classic case. Impact-generating investments are those where the investor's actions influence or enable the company's impact, for example providing seed capital that the market would not otherwise have supplied. Both are legitimate strategies. The credibility problem arises when funds present impact-aligned holdings as if they were impact-generating, claiming a causal role they did not play.

Before you invest: Estimating contribution potential

Contribution evidence starts before capital is deployed. Researchers propose a simple ex-ante heuristic, Investor Impact Potential:

‍

IIP = L × M (Likelihood of influence × Magnitude of resulting company impact)

‍

Likelihood depends on the mechanism.
Capital provision carries high likelihood when the company is young, the market is undersupplied, and growth is genuinely constrained by capital access; it carries low likelihood when the company has ample access to capital elsewhere. Non-financial support carries high likelihood when the investor offers expertise or networks the company could not easily buy; low likelihood for large companies with dispersed ownership. The pattern generalises: L is high where the investor provides something the market does not.

Magnitude deserves the same discipline, and is often skipped.
Assess it along the dimensions the field already uses for impact itself: how many people or how many tonnes are affected, how deep the change is for each, how long it lasts, and how underserved the target group or market is. A company at the intersection of climate and health in an emerging market has a higher M than a niche premium product in a saturated Western market.

The relationship is multiplicative: a high M cannot rescue a near-zero L. Documenting both scores, with rationale, in every investment committee memo takes an hour and creates the baseline against which all later contribution evidence is read.

Stage 2 in practice: Ask the investee

Here is the part most funds overlook. The most practical source of contribution evidence is not a financial model. It is the portfolio company itself.

Investee perception surveys are low-cost, high-signal, and generate qualitative evidence that no capital-share arithmetic can replicate. Grounded in the contribution categories synthesised by Busch et al. (2025) in their literature review on the effectiveness of investor impact mechanisms, the following instrument can be administered annually to all portfolio companies:

The instrument is deliberately standardisable: The same six questions, every portfolio company, every year. That consistency is what turns anecdote into evidence. Tracked longitudinally, the results give LPs something most funds cannot show today, the portfolio's own assessment of whether the fund made a difference.

leonardo offers this as a standardised annual assessment across portfolios, including survey administration, longitudinal tracking and an LP-ready summary of the results. If you want to see what this would look like for your portfolio, get in touch.

One survey alone does not prove causality, and it does not need to. Contribution evidence is strongest when three things line up: a record of what the fund actually did (mechanisms and activities, documented as they happen), the investee's perception of whether those actions mattered (the survey), and a temporal sequence in which changes in the company follow the fund's actions. None of the three is conclusive on its own. Together they form a contribution narrative that holds up in front of a sceptical LP.

Stage 3: capital-share contribution

For funds further along, contribution shares can be modelled pro rata to capital provided. Note the wording: capital, not equity. Outcomes are financed through equity, debt, mezzanine and grants alike, and a contribution basis should reflect all of them.

Capital-share modelling is an option, not a default, and it only makes sense under specific conditions: syndicated deals where all co-investors agree on the approach, ideally fixed at term sheet stage, and where Stage 1 data quality is already solid. Even then, capital share tells you who funded the outcome, not who drove it. An investor providing 5% of the capital who introduced the key enterprise customer that unlocked product-market fit contributed more than their share suggests. The investee survey is precisely what surfaces this asymmetry, which is why Stage 2 remains valuable even for funds operating at Stage 3.

What funds should do differently, starting this quarter

1. ‍Fix data collection first (Stage 1).
   Standardise impact KPI collection across all portfolio companies: consistent metrics, fixed schedule, clear owner on both sides. No methodology compensates for unreliable underlying data.‍
2. Score L and M at IC stage.
   Require explicit likelihood and magnitude scores with documented rationale in every IC memo. Ex-ante, not as a post-hoc reporting exercise.‍
3. Interview founders at due diligence.
   Before closing: who else was offering capital, and on what terms? What would your growth timeline look like without this investment? Document the answers. They become the counterfactual baseline against which the annual survey results are read.‍
4. Deploy the investee survey annually (Stage 2).
   Administer the instrument above, or an adapted version, to all portfolio companies each year. Track longitudinally and include the results in LP reports as qualitative contribution evidence.‍
5. Where the conditions are met, add a capital-share basis (Stage 3).
   Only in deals where co-investors align on the approach early, and always alongside, never instead of, the investee survey.

Toward an honest contribution practice

The strongest position a fund can take is not a precise percentage, but a clear statement of what it can evidence and what it cannot. A fund that says "we provided capital this company could not raise elsewhere, our portfolio companies confirm our role in their own words, and we do not claim a calculated share of every outcome" is more credible than one presenting an unexplained contribution figure to two decimal places.
The future of impact investing belongs to the funds that can answer, with evidence, one question: what would not have happened if we had not invested? Answering it does not require an econometrics department. It requires consistent data, a few honest questions asked at the right moments, and the discipline to write down the answers. That is a standard every fund can meet, starting now.